<DOC>
	<DOCNO>NCT01152931</DOCNO>
	<brief_summary>In last decade , prevalence malaria escalate alarm rate , especially Africa . An estimated 300 500 million case year cause 1.5 2.7 million death , 90 % occur child 5 year age Africa ( WHO 1995 ) . Malaria Africa 's leading cause under-five mortality ( 20 % ) constitute 10 % continent 's overall disease burden . It account 40 % public health expenditure , 30-50 % inpatient admission , 50 % outpatient visit area high malaria transmission . Antioxidant micronutrient immunomodulatory role may suppressive activity .</brief_summary>
	<brief_title>Antioxidant Micronutrients Malaria</brief_title>
	<detailed_description>The pathogenesis plasmodial infection hinge intracellular invasion host erythrocyte hepatocyte possible generation free radical may contribute cellular membrane damage . This make uninfected erythrocyte hepatocyte susceptible merozoite invasion . Zinc Selenium immunomodulatory property . They enhance cell-mediated immune response malaria infection . This may help adequately suppress schizont maturation inhibit release merozoite . However , possible direct chemosuppressive blood schizonticidal effect . The following research question emanate hypothesis ; 1 . Do micronutrient question direct suppressive schizonticidal effect ? 2 . Can use short course therapy standard antimalarial uncomplicated malaria ? 3 . Is effect enhance use combination standard antimalarial ? 4 . Do prophylactic benefit ? 5 . Can use alter course establish malaria infection ?</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Amodiaquine , artesunate drug combination</mesh_term>
	<criteria>age &lt; 5 year asexual parasitemia 1,000 100,000/µl acute manifestation malaria ( e.g. , history fever precede 24 hour temperature &gt; 37.5°C baseline ) body weight 5 30 kg ability tolerate oral therapy inform consent legal representative subject ( parent , possible ) , oral agreement child appropriate resident study area duration least 4 week adequate antimalarial treatment within previous 7 day use micronutrient last 2 week antibiotic treatment concurrent infection hemoglobin level &lt; 7 g/dl hematocrit &lt; 25 % leukocyte count &gt; 15,000/µl mixed plasmodial infection severe malaria , severe underlie disease concomitant disease mask assessment treatment response inflammatory bowel disease , disease causing fever</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Antioxidants</keyword>
	<keyword>Micronutrients</keyword>
	<keyword>Malaria</keyword>
	<keyword>focus determine effect antioxidant micronutrient malaria</keyword>
</DOC>